Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Thromboembolism 1Spinal Cord Neoplasms 1Respiratory Insufficiency 1Pneumonia 1Osteosarcoma 1Myocardial Infarction 1Lung Neoplasms 1Bone Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Dalteparin 4Saline Solution 3Gemcitabine 3Enoxaparin 3Warfarin 2Tinzaparin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Aspirin 2130-nm albumin-bound paclitaxel 2palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1apixaban 1alvocidib 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Rivaroxaban 1Pentetic Acid 1PEGPH20 1Nadroparin 1Minocycline 1Ketoconazole 1Heparin 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thromboembolism × Fluoridation × Clear all
NCT01370278 2023-08-25

Clearance Of Mucus In Stents (COMIS)

M.D. Anderson Cancer Center

Phase NA Completed
43 enrolled
Thoracic

Angina, Unstable, Arrhythmias, Cardiac, Lung Neoplasms, Myocardial Infarction, Pneumonia, Respiratory Insufficiency, Thromboembolism, Acute Coronary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡